Johnson & Johnson, New Brunswick, N.J., and Watson Pharmaceuticals, Corona, Calif., said they have received separate subpoenas from federal agencies. J&J said the U.S. attorney's office in Boston has asked for information about an epilepsy drug made by J&J subsidiary Ortho-McNeil Pharmaceutical. Watson said HHS' inspector general's office is seeking information about physician meetings in connection with the company's anti-anemia drug. The U.S. attorneys in Boston and Philadelphia, the U.S. Justice Department, HHS and several state attorneys general are investigating the sales and marketing practices of as many as 20 pharmaceutical companies. The allegations range from manipulating pricing data to paying kickbacks. -- by Mark Taylor
Two drugmakers disclose government subpoenas
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.